JP2007524633A5 - - Google Patents

Download PDF

Info

Publication number
JP2007524633A5
JP2007524633A5 JP2006517702A JP2006517702A JP2007524633A5 JP 2007524633 A5 JP2007524633 A5 JP 2007524633A5 JP 2006517702 A JP2006517702 A JP 2006517702A JP 2006517702 A JP2006517702 A JP 2006517702A JP 2007524633 A5 JP2007524633 A5 JP 2007524633A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
independently hydrogen
alkyl
bcl
gallate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006517702A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007524633A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/020569 external-priority patent/WO2005009434A2/en
Publication of JP2007524633A publication Critical patent/JP2007524633A/ja
Publication of JP2007524633A5 publication Critical patent/JP2007524633A5/ja
Pending legal-status Critical Current

Links

JP2006517702A 2003-06-25 2004-06-25 癌細胞におけるアポトーシスの誘導のための化合物および方法 Pending JP2007524633A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48288603P 2003-06-25 2003-06-25
PCT/US2004/020569 WO2005009434A2 (en) 2003-06-25 2004-06-25 Compounds and methods for inducing apoptosis in cancer cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011215077A Division JP2012025767A (ja) 2003-06-25 2011-09-29 癌細胞におけるアポトーシスの誘導のための化合物および方法

Publications (2)

Publication Number Publication Date
JP2007524633A JP2007524633A (ja) 2007-08-30
JP2007524633A5 true JP2007524633A5 (cg-RX-API-DMAC7.html) 2008-12-18

Family

ID=34102647

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006517702A Pending JP2007524633A (ja) 2003-06-25 2004-06-25 癌細胞におけるアポトーシスの誘導のための化合物および方法
JP2011215077A Pending JP2012025767A (ja) 2003-06-25 2011-09-29 癌細胞におけるアポトーシスの誘導のための化合物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011215077A Pending JP2012025767A (ja) 2003-06-25 2011-09-29 癌細胞におけるアポトーシスの誘導のための化合物および方法

Country Status (13)

Country Link
US (3) US7812058B2 (cg-RX-API-DMAC7.html)
EP (2) EP1653943B3 (cg-RX-API-DMAC7.html)
JP (2) JP2007524633A (cg-RX-API-DMAC7.html)
AT (2) ATE478663T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004258867B2 (cg-RX-API-DMAC7.html)
CA (1) CA2529507C (cg-RX-API-DMAC7.html)
DE (2) DE602004012279T3 (cg-RX-API-DMAC7.html)
DK (1) DK1653943T4 (cg-RX-API-DMAC7.html)
ES (2) ES2303096T7 (cg-RX-API-DMAC7.html)
PL (1) PL1653943T6 (cg-RX-API-DMAC7.html)
PT (1) PT1653943E (cg-RX-API-DMAC7.html)
SI (1) SI1653943T1 (cg-RX-API-DMAC7.html)
WO (1) WO2005009434A2 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7432304B2 (en) 2001-05-30 2008-10-07 The Regents Of The University Of Michigan Small molecule antagonists of Bcl-2 family proteins
US7354928B2 (en) * 2001-11-01 2008-04-08 The Regents Of The University Of Michigan Small molecule inhibitors targeted at Bcl-2
PL1653943T6 (pl) 2003-06-25 2009-02-27 The Burnham Inst La Jolla Pochodne katecholu do leczenia raka
CA2561303C (en) * 2004-03-25 2011-01-18 The Regents Of The University Of Michigan Gossypol co-crystals and the use thereof
US20060144723A1 (en) * 2004-11-02 2006-07-06 Mary Fuller Device for securing valuables
EP2197273B1 (en) * 2007-10-01 2014-09-24 Ascenta Therapeutics, Inc. Process for preparing r-gossypol l-phenylalaninol dienamine
US9115061B2 (en) * 2007-10-19 2015-08-25 Burnham Institute For Medical Research Naphthalene-based inhibitors of anti-apoptotic proteins
FR2924712B1 (fr) 2007-12-06 2012-12-21 Univ Maine Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications
GB0725077D0 (en) * 2007-12-21 2008-01-30 Univ Murcia Antifolate com[ounds for the treatment of melanoma
WO2009126172A1 (en) * 2008-04-11 2009-10-15 The Trustees Of Columbia University In The City Of New York Resistance to polyphenon e due to increased bcl-2 expression
WO2010019914A2 (en) * 2008-08-14 2010-02-18 The Uab Research Foundation Anti-arrhythmia agents, methods of their use, methods for their identification, and kits thereofre
US8487131B2 (en) 2009-04-15 2013-07-16 Sanford-Burnham Medical Research Institute Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
BRPI1016102A2 (pt) 2009-04-15 2015-09-01 Sanford Burhnham Medical Res Inst Inibidores de proteínas anti-apoptótica baseados em naftaleno
US8772264B2 (en) 2009-08-04 2014-07-08 Mayo Foundation For Medical Education And Research Methods of treating hematologic cancers
EP2485721A4 (en) 2009-10-08 2016-05-18 Sanford Burnham Med Res Inst APOGOSSYPOLON DERIVATIVES AS ANTICREMENTS
EP2956470A4 (en) * 2013-02-15 2016-12-07 Univ Michigan Regents COMPOSITIONS AND METHODS RELATED TO PREVENTING DOT1L RECRUITMENT BY MLL FUSION PROTEINS
US9655998B2 (en) 2014-08-07 2017-05-23 Cook Medical Technologies Llc Encapsulated drug compositions and methods of use thereof
US9180226B1 (en) 2014-08-07 2015-11-10 Cook Medical Technologies Llc Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof
US11241520B2 (en) 2014-08-07 2022-02-08 Cook Medical Technologies Llc Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof
US10195213B2 (en) 2015-03-13 2019-02-05 Unity Biotechnology, Inc. Chemical entities that kill senescent cells for use in treating age-related disease
JP2018512450A (ja) * 2015-03-19 2018-05-17 ウェンディ アン エプスタインEPSTEIN, Wendy Anne 女性の性的障害を治療するための化合物及び剤型
RU2654711C1 (ru) * 2017-07-10 2018-05-22 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Средство, обладающее апоптоз-индуцирующей активностью
KR102614471B1 (ko) * 2018-04-20 2023-12-14 나이키 이노베이트 씨.브이. 플레이트들 및 개재된 유체 충전 블래더를 구비하는 솔 구조체 및 제조 방법
CN110128290B (zh) * 2019-05-10 2022-04-29 江苏耐雀生物工程技术有限公司 红倍酚苯甲酰肼衍生物、中间体、制备方法及其应用
CA3155694A1 (en) * 2019-09-24 2021-04-01 Genetec Inc. Intermediary device for daisy chain and tree configuration in hybrid data/power connection

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5385936A (en) * 1990-07-12 1995-01-31 The United States Of America As Represented By The Secretary Of The Department Of The Health And Human Services Gossypol acetic acid for the treatment of cancer
US5804567A (en) * 1996-07-18 1998-09-08 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method of increasing the effectiveness of anti-metabolites
JPH1036260A (ja) * 1996-07-18 1998-02-10 Mitsui Norin Kk 抗ガン剤の効力増強方法
US6428818B1 (en) * 1999-03-30 2002-08-06 Purdue Research Foundation Tea catechin formulations and processes for making same
JP2005502579A (ja) * 2000-12-15 2005-01-27 ワックヴォム リミテッド 新生血管形成に関連する状態を処置するための方法および組成物
ATE474568T1 (de) * 2001-05-30 2010-08-15 Univ Michigan Synergistische kombination von (-) -gossypol mit docetaxel oder paclitaxel zur behandlung von krebs.
US7432304B2 (en) * 2001-05-30 2008-10-07 The Regents Of The University Of Michigan Small molecule antagonists of Bcl-2 family proteins
PL1653943T6 (pl) 2003-06-25 2009-02-27 The Burnham Inst La Jolla Pochodne katecholu do leczenia raka

Similar Documents

Publication Publication Date Title
CA2529507A1 (en) Compounds and methods for inducing apoptosis in cancer cells
Kitada et al. Discovery, characterization, and structure− activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins
Mackenzie et al. Curcumin induces cell‐arrest and apoptosis in association with the inhibition of constitutively active NF‐κB and STAT3 pathways in Hodgkin's lymphoma cells
Wei et al. BI-97C1, an Optically Pure Apogossypol Derivative as Pan-Active Inhibitor of Anti-apoptotic B-cell lymphoma/leukemia-2 (Bcl-2) Family Proteins
Leone et al. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins
US9988405B2 (en) O-phenyl chalcone compounds and uses thereof
Xie et al. Capsaicin and dihydrocapsaicin induce apoptosis in human glioma cells via ROS and Ca2+-mediated mitochondrial pathway
Wei et al. Apogossypol Derivatives as Pan-active Inhibitors of Anti-apoptotic B-cell lymphoma/leukemia-2 (Bcl-2) Family Proteins
Liu et al. Effect of fraxetin on proliferation and apoptosis in breast cancer cells
Li et al. Pt (IV) prodrugs containing microtubule inhibitors displayed potent antitumor activity and ability to overcome cisplatin resistance
Kaplancıklı et al. Synthesis and antiproliferative activity of new 1, 5-disubstituted tetrazoles bearing hydrazone moiety
Srivastava et al. Synthesis and bio-evaluation of novel quinolino-stilbene derivatives as potential anticancer agents
Tan et al. Pterostilbene inhibits lung squamous cell carcinoma growth in vitro and in vivo by inducing S phase arrest and apoptosis
Rodrigues et al. Effect of quinolinyl acrylate derivatives on prostate cancer in vitro and in vivo
Lee et al. [NiII (3-OMe-salophene)]: a potent agent with antitumor activity
Wang et al. Targeting procaspase‐3 with WF‐208, a novel PAC‐1 derivative, causes selective cancer cell apoptosis
Li et al. Synthesis and biological evaluations of N′-substituted methylene-4-(quinoline-4-amino) benzoylhydrazides as potential anti-hepatoma agents
Wei et al. Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of anti-apoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins
Yang et al. Redox cycling of a copper complex with benzaldehyde nitrogen mustard-2-pyridine carboxylic acid hydrazone contributes to its enhanced antitumor activity, but no change in the mechanism of action occurs after chelation
AU2016212552B2 (en) Compound containing indoleacetic acid core structure and use thereof
EP3634403B1 (en) Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma
Mao et al. 1, 2, 3-Triazole-modified sorafenib derivatives induce DNA damage, apoptosis, and PI3K/AKT pathway suppression in hepatocellular carcinoma: Design, synthesis, and evaluation
Balachandran et al. Synthetic investigation on chirally pure Mannich derivatives of pseudophenylpropanolamine and their anticancer properties against HepG-2 cells with inhibition of JAK2/STAT3
CN110551156A (zh) 特定基团修饰的n1,n3取代4,5-二芳基咪唑环卡宾铑配合物及其制备方法和应用
CN113200908B (zh) 一种含叔胺的邻氨基苯甲酰胺类化合物及其制备与应用